Registration

PRIME POLICY GROUP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

COVID-19 vaccine and therapy development and deployment

LobbyistCovered position, as disclosed
STEFAN BAILEY New 2003-2004: Legislative Assistant, Rep. Baron Hill (IN-09); 2004-2005: Press Secretary/Legislative Director, Rep. Baron Hill (IN-09); 2005-2007: Legislative Director, Rep. Nick Rahall (WV-03)
EMILY AUSTEN KATZ New 2013-15: Senior Health Policy Advisor, Sen. Barbara Boxer; 2010-13: Health Policy Director, Rep. Diana DeGette; 2009-10: Legislative Assistant, Sen. Ron Wyden; 2005-07: Legislative Aide, Sen. Ron Wyden; 2004: Biomedical Ethics Intern (Paid), NIH
RICH MEADE New 1997-2003: Chief of Staff, Rep. Jim Nussle; 2001-05: Chief of Staff, Committee on the Budget, House of Representatives

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ASTRAZENECA PLC United Kingdom United Kingdom 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.